These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors. Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW. Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300 [Abstract] [Full Text] [Related]
23. Sphingosine kinase 1 is up-regulated in colon carcinogenesis. Kawamori T, Osta W, Johnson KR, Pettus BJ, Bielawski J, Tanaka T, Wargovich MJ, Reddy BS, Hannun YA, Obeid LM, Zhou D. FASEB J; 2006 Feb; 20(2):386-8. PubMed ID: 16319132 [Abstract] [Full Text] [Related]
24. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers. Yan M, Rerko RM, Platzer P, Dawson D, Willis J, Tong M, Lawrence E, Lutterbaugh J, Lu S, Willson JK, Luo G, Hensold J, Tai HH, Wilson K, Markowitz SD. Proc Natl Acad Sci U S A; 2004 Dec 14; 101(50):17468-73. PubMed ID: 15574495 [Abstract] [Full Text] [Related]
25. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1. Bissonnette M, Khare S, von Lintig FC, Wali RK, Nguyen L, Zhang Y, Hart J, Skarosi S, Varki N, Boss GR, Brasitus TA. Cancer Res; 2000 Aug 15; 60(16):4602-9. PubMed ID: 10969813 [Abstract] [Full Text] [Related]
26. Enhancement of experimental colon cancer by genistein. Rao CV, Wang CX, Simi B, Lubet R, Kelloff G, Steele V, Reddy BS. Cancer Res; 1997 Sep 01; 57(17):3717-22. PubMed ID: 9288778 [Abstract] [Full Text] [Related]
27. Differential modulation of transforming growth factor-betas and cyclooxygenases in the platelet lysates of male F344 rats by dietary lipids and piroxicam. Raju J, Bird RP. Mol Cell Biochem; 2002 Feb 01; 231(1-2):139-46. PubMed ID: 11952155 [Abstract] [Full Text] [Related]
28. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV. Cancer Res; 2000 Jan 15; 60(2):293-7. PubMed ID: 10667579 [Abstract] [Full Text] [Related]
29. Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer. Biswas S, Chytil A, Washington K, Romero-Gallo J, Gorska AE, Wirth PS, Gautam S, Moses HL, Grady WM. Cancer Res; 2004 Jul 15; 64(14):4687-92. PubMed ID: 15256431 [Abstract] [Full Text] [Related]
30. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1. Picon A, Gold LI, Wang J, Cohen A, Friedman E. Cancer Epidemiol Biomarkers Prev; 1998 Jun 15; 7(6):497-504. PubMed ID: 9641494 [Abstract] [Full Text] [Related]
31. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions. Berger DH, O'Mahony CA, Sheng H, Shao J, Albo D, DuBois RN, Beauchamp RD. Surgery; 2003 May 15; 133(5):568-79. PubMed ID: 12773985 [Abstract] [Full Text] [Related]
32. Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer. Refaat B, El-Shemi AG, Kensara OA, Mohamed AM, Idris S, Ahmad J, Khojah A. J Exp Clin Cancer Res; 2015 Jul 25; 34(1):71. PubMed ID: 26205949 [Abstract] [Full Text] [Related]
33. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. Gustafson-Svärd C, Lilja I, Hallböök O, Sjödahl R. Gut; 1996 Jan 25; 38(1):79-84. PubMed ID: 8566864 [Abstract] [Full Text] [Related]
34. Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells. Saha D, Datta PK, Sheng H, Morrow JD, Wada M, Moses HL, Beauchamp RD. Neoplasia; 1999 Dec 25; 1(6):508-17. PubMed ID: 10935498 [Abstract] [Full Text] [Related]
36. Expression of cyclooxygenase-2 (COX-2) mRNA in human colorectal adenomas. Hasegawa K, Ichikawa W, Fujita T, Ohno R, Okusa T, Yoshinaga K, Sugihara K. Eur J Cancer; 2001 Aug 25; 37(12):1469-74. PubMed ID: 11506952 [Abstract] [Full Text] [Related]
37. Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine. von Rahden BH, Brücher BL, Langner C, Siewert JR, Stein HJ, Sarbia M. Br J Surg; 2006 Nov 25; 93(11):1424-32. PubMed ID: 17022010 [Abstract] [Full Text] [Related]
38. Effects of adlay on azoxymethane-induced colon carcinogenesis in rats. Shih CK, Chiang W, Kuo ML. Food Chem Toxicol; 2004 Aug 25; 42(8):1339-47. PubMed ID: 15207385 [Abstract] [Full Text] [Related]
39. Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer. Khare S, Cerda S, Wali RK, von Lintig FC, Tretiakova M, Joseph L, Stoiber D, Cohen G, Nimmagadda K, Hart J, Sitrin MD, Boss GR, Bissonnette M. Cancer Res; 2003 Jul 01; 63(13):3517-23. PubMed ID: 12839936 [Abstract] [Full Text] [Related]
40. TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. Avery A, Paraskeva C, Hall P, Flanders KC, Sporn M, Moorghen M. Br J Cancer; 1993 Jul 01; 68(1):137-9. PubMed ID: 8318404 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]